Speakers are listed in order of presentation as per programme

Wednesday 18 May 2022

Dali Magazi (SA)

Professor Dali Magazi is the Immediate past president of the South African chapter of the ILAE (International League Against Epilepsy). A recipient of numerous awards on teaching excellence, including a national prize by nomination. Published in national and international journals and presented in national and international platforms. Presently professor and HOD of the department of Neurology, Sefako Makgatho Health Sciences University.

Wiebren Duim (SA)

Dr Wiebren Duim is a neurologist in private practice since August 1995 – initially Eugene Marais Hospital and since 1995 at Life Groenkloof Hospital (2004) the old LCM. Moved to LCM to run a multi-disciplinary stroke unit with a dedicated neurology ward. Still doing exactly that. Started a database on 1 July 2015 and now presenting 750 patients from that database.

N.V Ramani (Singapore)

Professor Ramani is a consultant neurologist at Raffles Neuroscience Center in Raffles Hospital and an Associate Professor with the Department of Medicine and Department of Epidemiology and Public Health of Yong Loo Lin School of Medicine in Singapore. He has special interests in stroke, neurosonology, epidemiology and clinical trials, and has published multiple book chapters regarding these topics. He is a member of numerous local and international committees as well as an editorial board member and reviewer for several peer-reviewed journals related to medicine, neurology and stroke. Professor Ramani is one of the primary investigators for the CHIMES-E trial.

Patty Francis (SA)

Dr Patty Francis is the current President of the Neurological Association of South Africa (NASA). She has a special interest in stroke and is part of an acute stroke service at Umhlanga Hospital. Other special interests are headaches, MS, Parkinson's disease, peripheral neuropathies, and dementia. In 2018, she was awarded the Angels Spirit of Excellence award for acute stroke care

Louis Kroon (SA)

Dr Louis Kroon is an attending neurologist at Steve Biko Academic Hospital and lecturer at the University of Pretoria. He completed his neurology registrars training at the University of Pretoria (with Distinction) and is currently working on his doctoral dissertation. His most recent published work includes an article in the journal of Stroke and Cerebrovascular disease on the risk factors of HIV and Stroke for which he also received the reward for best NASA/AFAN research presentation in 2019. Dr Kroon also facilitated the Diamond Stroke Status award for Steve Biko Academic Hospital in 2022. Currently he serves as an examiner for the colleges of medicine of South Africa, and is part of the Committee of the Civil Aeromedical Association. He is also setting up the AAN’s Residency in Training Examination program (RITE) at the University of Pretoria.

Rupal Sedani (Czech Republic)

Rupal Sedaniis a Global manager for RES-Q registry, based out of Brno, Czech Republic. Rupal has experience of > 20 years in the India healthcare industry and has worked in the field of Sales, Marketing research, Marketing and Project management with organizations like Novartis, Pfizer, Boehringer Ingelheim. Rupal established and lead the Angels Initiative project in India and since 2021, managing the Quality registry of Stroke , RES-Q.

Fleur van Rootselaar (Netherlands)

Dr. A. Fleur van Rootselaar is a Neurologist and Clincial Neurophysiologist working at the Amsterdam University Medical Centers, Amsterdam, The Netherlands. Over the past fifteen years she has been involved in care for comatose and postanoxic patients. Dr. Fleur van Rootselaar is co-author on national and international publications about prognostication and treatment of ‘status epilepticus’ in postanoxic patients. She is supervising PhD-students looking into validation of a simplified EEG recording system and using artificial intelligence for EEG interpretation. Dr. Van Rootselaar works with a number of national and international groups and colleagues, also to implement novel findings in clinical practice.

Alfonso Fasano (Canada)

Professor Alfonso Fasano holds the Chair in Neuromodulation at the University of Toronto and University Health Network. He is a Professor in the Department of Medicine (Division of Neurology) at the University of Toronto and staff neurologist and co-director of the Surgical Program for Movement Disorders at Toronto Western Hospital, University Health Network. He is also staff neurologist at the Hospital of Sick Children in Toronto. Dr. Fasano is a Clinician Investigator at the Krembil Research Institute and KITE – Toronto Rehabilitation Hospital. Dr. Fasano leads the Core E (closed-loop capabilities) of the CenteR for Advancing Neurotechnological Innovation to Application (CRANIA) and sits in the scientific advisory board of the Dystonia Medical Research Foundation and International Essential Tremor Foundation. He’s the chair of the Normal Pressure Hydrocephalus study group of and member of the study group on tremor of the International Parkinson Movement Disorders Society; he’s also member of the Tremor Research Group and the Parkinson Study Group. Dr. Fasano received his medical degree from the Catholic University of Rome, Italy, in 2002 and became a neurologist in 2007. After a 2-year fellowship at the University of Kiel, Germany, he completed a PhD in neuroscience at the Catholic University of Rome. His main areas of interest are the treatment of movement disorders with advanced technology (infusion pumps and neuromodulation), pathophysiology, and treatment of tremor and gait disorders. He authored more than 400 scientific papers and book chapters. Dr. Fasano is the co-editor of the section “Gaps and Controversies” of Movement Disorders Journal and editorial board member of Annals of Neurology, Movement Disorders Journal, Movement Disorders Clinical Practice and Parkinsonism and Related Disorders. He is also the principal investigator of several clinical trials.

Alberto Espay (USA)

Professor Alberto Espay is Professor and Endowed Chair of the James J. and Joan A. Gardner Center for Parkinson’s disease at the University of Cincinnati. He has published over 300peer-reviewed research articlesand8books, including Common Movement Disorders Pitfalls, which received the Highly Commended BMA Medical Book Award in2013 and Brain Fables, the Hidden History of Neurodegenerative Diseases and a Blueprint to Conquer them, co-authored with Parkinson patient and advocate Benjamin Stecher, selected by the Association of American Publishers for the PROSE Award honoring the best scholarly work in Neuroscience published in 2020.He has served as Chair of the Movement Disorders Section of the American Academy of Neurology, Associate Editor of the Movement Disorders journal, and on the Executive Committee of the Parkinson Study Group. Among other honors, he has received the Cincinnati Business Courier’s Health Care Hero award, the Spanish Society of Neurology’s Cotzias award, and honorary membership in the Mexican Academy of Neurology. He currently serves as President-Elector of the Pan-American Section of the International Parkinson and Movement Disorders Society. With colleagues at the University of Cincinnati, he recently launched the first biomarker study of aging (CCBPstudy.com), designed to match people with neurodegenerative disorders to available therapies from which they are most biologically suitable to benefit, regardless of their clinical diagnoses.

Ray Chaudhuri (UK)

Professor K. Ray Chaudhuri is Professor of Neurology/Movement Disorders at King’s College Hospital and King’s College London and the Medical Director of the Parkinson Foundation International Centre of Excellence at King’s College. He is internationally known for pioneering modern care for people with Parkinson’s particularly advanced therapies in addition to care for restless legs syndrome. He is the founding Chairman of the International Movement Disorders Society Non-motor Study Group and member MDS-ES Education and palliative care committee and ex Chair of the MDS Membership and Public Relations committee as well as member MDS congress scientific programme committee (2013–2017). He is the founding and consulting editor and ex editor-in- chief of the Nature group Nature Parkinson’s journal (2020 Impact Factor 8.8) as well as guest Editor for special editions of Frontiers in Neurology, Journal of Personalised Medicine (Impact Factor 4.8), Movement Disorders in Older Adults (Geriatrics) and Journal of Parkinson’s Disease, reviewer for all mainstream Movement Disorders journals as well as JAMA, Neurology, Annals of Neurology, BMJ, Brain, Lancet and JNNP. He serves as an advisor (MHRA health technology and scientific advisor) to NICE as well as GMC, Parkinson’s UK and EPDA. Professor Chaudhuri is the author of over 480 papers ( 6th most published author in the world in PD 2022,Expertscape) , co-editor of five books on Parkinson’s disease and restless legs syndrome and winner of the BMA book prize commendation in 2015 and 2017. He won the Andrew Wilson Prize for services to RLS patients by RLS: UK, William Koller Memorial Fund Award by MDS, the 2018 Van Andel award in the USA for outstanding nonmotor research contribution in the field of nonmotor Parkinson, as well as NIHR/Royal College of Physicians London award for outstanding research leadership in 2017. He has been a guest lecturer worldwide including Japan, China, Taiwan, Vietnam, Thailand, Singapore, Australia, India, Africa, USA, Russia and Europe. In 2020 he was elected as lead for Equality Diversity charter for NIHR London South Applied Research Collaboration (ARC) and was elected as a Honorary Member for the Movement Disorders Society in 2021. In 2022 he was awarded UK NHS Gold merit award.

James Butler (SA)

Dr James Butler is a neurologist who specialises in epilepsy, including epilepsy surgery, and has a strong interest in evidence-based medicine. He qualified from the University of Cape Town in 1988, completed his neurology training at the same institution in 1995, and did a two-year fellowship in epilepsy at the Epilepsy Unit in the Department of Neurological Sciences, University of Western Ontario, Canada from 1996 to 1998. During his time there, he completed six courses towards a certificate in clinical epidemiology and biostatistics from the same institution. He was subsequently appointed as a consultant neurologist at the University of Stellenbosch, before starting the Epilepsy Unit at Constantiaberg Hospital, Cape Town in 2000. He established a research unit in the same hospital, is affiliated as a part-time consultant to the Neurology Department at the University of Cape Town and the University of Stellenbosch, and has published 16 articles in international peer-reviewed journals, including one of the two completed randomised controlled trials of epilepsy surgery in adults. He has collaborated on projects with the Swiss Epilepsy Centre in Zurich. He serves as a member of the Neurological Association of South Africa executive committee. He has held a weekly Friday morning neurosciences meeting for more than a decade, attended by the trainees and consultants at the local universities and, with the advent of the pandemic, this has evolved into a digital weekly meeting attended by clinicians from across South Africa and Africa. He has also done weekly EEG teaching for local trainees and consultants for many years, broadened to a weekly digital teaching session in 2020. He supervised the epilepsy clinic and held a weekly Evidence-based Neurology Journal Club at Tygerberg Hospital for approximately 20 years.

Shaquir Salduker (SA)

Dr Shaqir Salduker is aPsychiatrist in private practice with a special interest in Pain, consultation liaison psychiatry and Adult ADHD. Dr Salduker is also a Director of PsychMg.

Hemant Nowbath (SA)

Dr Hemant Nowbath is a psychiatrist in private practice in Durban. He qualified in Medicine at the University of the Witwatersrand and specialised in Kwazulu-Natal.An avowed hedonist, he dabbles in psychiatry and seeks truth in golf and good whisky. Bereft of any academic honours he is a founder member and past president of the South African Addiction Medicine Society and served on the executive of the Durban Chess Club.

Thursday 19 May 2022

Bruce Cree (USA)

Professor Bruce Cree is a Professor ofClinical Neurology and is the George A. Zimmermann Endowed Professor in Multiple Sclerosis in the Department of Neurology at the University of California San Francisco. Dr. Cree completed his MD and PhD in Biochemistry at UCSF. His neurology residency training was at Columbia University. He returned to UCSF for a Sylvia Lawry National Multiple Sclerosis Society fellowship and received a Masters in Advanced Studies in Clinical Research. He is the Clinical Research Director at the UCSF MS Centre. He divides his time between patient care, clinical research and teaching. His research focuses on the genetic epidemiology of multiple sclerosis, understanding factors that contribute to disease progression and developing novel therapies for MS through clinical trials. In addition to multiple sclerosis, Dr. Cree specializes in research and care of patients with neuromyelitisoptica and transverse myelitis.

Michael Strupp (Germany)

Professor Michael Strupp has a particular interest in the diagnosis and therapy of vestibular, ocular motor and cerebella disorders. He has authored 440 Pumed listed papers (h-index:85) and 5 books. Some of his major achievements are: First, demonstration of the effectiveness of vestibular exercises in acute vestibular neuritis in a controlled clinical trial. Second, the benefit of steroids in acute vestibular neuritis, a placebo-controlled, four –arm trial published in the NEJM. Third, introduction of three new therapeutic principles: aminopyridines, as potassium channel blockers, for the treatment of downbeat, upbeat and central positioning nystagmun as well as episodic ataxia type 2; and ecetyl-DL-leucine for the treatment of ataxias and Niemann-Pick Type C. Fourth, the development of new light and practical examination glasses for nystagmus: the “M glasses” and the “positional vertigo App”. He has been the principal investigator of eleven clinical trials. He is also very much engaged in the “International Classification of Vestibular Disorders”. He is Joint Chief Editor of the Journal of Neurology and Editor of Frontiers in Neuro-otology. He has received many clinical and scientific awards, including the Hallpike-Nylen Award 2016, an Investigator Award by the European Academy of Neurology 2019, The Galenus-von-Pergamon Award 2020, and was awarded ‘Best Teacher’ by the German Neurological Society.

Louis Hofmeyr (SA)

Dr Louis Hofmeyr studied medicine and specialised in ENT at the University of Pretoria (UP). He has worked exclusively as an otologist and neurotologist with more than 25 years of experience managing patients with vestibular and auditory disorders. After completing his studies, he worked at 1 Military Hospital, where he progressed to Chief ENT Specialist, Head of the Department of ENT at 1 Military Hospital and the Institute for Aviation Medicine in Centurion, and Chief ENT surgeon of the South African National Defence Force (SANDF). He was a previous Adjunct Professor in ENT at the UP and is currently affiliated with the Department of ENT at the University of Stellenbosch (US) as a part-time lecturer. He is a part-time researcher in the Department of Speech-Language Pathology and Audiology at UP. He is currently an Associate Editor of Frontiers in Neuro-otology. His particular area of interest is vertigo, balance disorders, hearing loss, cochlear implantation, implantable hearing devices, ear diseases, vestibular schwannomas, Bell's palsy, tinnitus, and marble bone disease (sclerosteosis). His significant achievements are: First, managing over 500 patients with vestibular schwannomas (acoustic neuromas), the largest case series in Africa. Second, diagnosing and operating the first patient with superior canal dehiscence (SCDS) in South Africa and since managed more than 100 patients with this condition. Thirdly, he has performed over 250 cochlear implants (CI), including the first CI in Namibia. Lastly, he is the only ENT surgeon in South Africa who regularly performs middle cranial fossa surgery and the transtemporal supralabyrinthine approach. He is a founding member of Cape Hearing implants (CHi), a non-profit collaboration of health care specialists offering CI and other implantable hearing solutions to less fortunate patients. He is also part of the Cape Town Balance & Hearing Center, where he manages a vestibular laboratory in the CBMH. Louis has a passion for teaching and established the first temporal bone course in Pretoria and the Update In The Management Of Patients With Vestibular Disorders, of which three have now been hosted. He is part of the faculty of the annual Cape Town Temporal Bone course at US. He has presented at numerous courses, published in many international, peer-reviewed journals, and contributed to four books. His most recent contribution is as the editor of the research project "Alteration of vestibular function in cochlear implantation." for Frontiers of Neurology.

James Butler (SA)

Dr James Butler is a neurologist who specialises in epilepsy, including epilepsy surgery, and has a strong interest in evidence-based medicine. He qualified from the University of Cape Town in 1988, completed his neurology training at the same institution in 1995, and did a two-year fellowship in epilepsy at the Epilepsy Unit in the Department of Neurological Sciences, University of Western Ontario, Canada from 1996 to 1998. During his time there, he completed six courses towards a certificate in clinical epidemiology and biostatistics from the same institution. He was subsequently appointed as a consultant neurologist at the University of Stellenbosch, before starting the Epilepsy Unit at Constantiaberg Hospital, Cape Town in 2000. He established a research unit in the same hospital, is affiliated as a part-time consultant to the Neurology Department at the University of Cape Town and the University of Stellenbosch, and has published 16 articles in international peer-reviewed journals, including one of the two completed randomised controlled trials of epilepsy surgery in adults. He has collaborated on projects with the Swiss Epilepsy Centre in Zurich. He serves as a member of the Neurological Association of South Africa executive committee. He has held a weekly Friday morning neurosciences meeting for more than a decade, attended by the trainees and consultants at the local universities and, with the advent of the pandemic, this has evolved into a digital weekly meeting attended by clinicians from across South Africa and Africa. He has also done weekly EEG teaching for local trainees and consultants for many years, broadened to a weekly digital teaching session in 2020. He supervised the epilepsy clinic and held a weekly Evidence-based Neurology Journal Club at Tygerberg Hospital for approximately 20 years.

Suzanne Hodgkinson (Australia)

Professor Suzanne Hodgkinson is an Associate Professor in Neurology at UNSW and a consultant Neurologist at the Liverpool Hospital in Australia. After completing a PhD in autoimmune neurological disease at the University of Sydney she worked with Professor Lawrence Steinman at Stanford University. Following her return to Sydney she has worked in both clinical trials for multiple sclerosis and in the laboratory with a focus on antigen activated specific T regulatory cells. In 1994, her autoimmune research team started working with the transplant research team at Liverpool Hospital in a collaborative way. In 2005, the two groups joined resources to form the Immune Tolerance Laboratory. She was one of the first to introduce using MRI activity as an endpoint for Phase 2 and 3 clinical trials and has been a PI for many of the significant new therapeutics in the field of Multiple Sclerosis. Some of the current trials include using BTKi inhibitors and CD8+ T cells directed against the EB virus. The Immune Tolerance Laboratory conducts research into the cellular and cytokine mechanisms of immune tolerance that occurs in transplantation models, and models of neurological autoimmunity. The work is being progressed to apply the same findings to humans.

Jeannine Owen (SA)

Dr Owen obtained her MBChB) was from the University of the Free State in 2006. She obtained her radiological qualification (FC Diag Rad) through the University of Cape Town in 2015 as well as Master of Medicine degree (MMED) in 2015. She then moved to private practice and has been working at Cape Radiology ever since. She obtained her Diploma in Neuroradiology through the European board of Neuroradiology in 2018 and became a partner at Cape Radiology in 2019.

Pradeep Rowji (SA)

Dr Pradeep Rowji is a Specialist Neurologist in Private Practice at Milpark Hospital, Johannesburg, with over 20 years post qualification experience.He is experienced in Neurological Emergencies and Stroke Management and, was instrumental in setting the Acute Stroke Services at Milpark Hospital. The Milpark stroke unit is the First Accredited Level One Stroke Unit in the country.DrRowji’s other expertise include Epilepsy and Status Epilepticus, Neuro-intensive care, Multiple Sclerosis and AIDP/CIDP.He is a member of the Neurology Association of South Africa, South African Society of Thrombosis and Haemostasis, and PSRT for SISONKE Trial.Dr Rowji has a number of publications under his name, the latest being “Effectiveness of the Ad26.COV2.S vaccine in healthcare workers in South Africa”. A single-arm, open-label, phase 3B, implementation study published in the Lancet Medical Journal.

Riaan van Coller (SA)

Riaan van Coller has a neurology practice at Wilgers Medical Centre, Pretoria. He received his medical and neurology training at the University of Pretoria. Dr van Coller has an interest in Parkinson’s disease and Movement Disorders, genetic causes in Parkinsonism and dystonia, Botulinum toxin treatment for dystonia and Deep Brain Stimulation for movement disorders. He is a consultant and lecturer at the Neurology Department, University of Pretoria. Dr van Coller’s affiliations include the Neurology Association of South Africa and the International Parkinson’s disease and Movement Disorders Society, where he is a member of the African Section Executive Committee.

Andres Deik (USA)

Professor Andres Deik is a graduateof the Uneversidad del Norte in his native Barranquilla, Colombia. He completed his residency in Neorology and fellowship in Movement Disorder at Mount Sinai Bet Israel, In New York City. He was also awarded a scholarship from the Dystonia, and completed a Master’s in Medical Education at the University of Pennsylvania. He is currently Associate Professor of Clinical Neurology and Associate Program Director of the Movement Disorders fellowship program at the University of Pennsylvania in Philadelphia, PA. He is also Director of Experiment Therapeutics at this institution. He devotes his time care (including administration of botulinum toxin injection and DBS programming), teaching and clinical trials in movement disorders.

Linette van Niekerk (SA)

Dr. Linette van Niekerk is a dedicated neurologist in full-time private practice in Pretoria, South Africa. She is passionate about her work and her patients, and although she treats an extensive variety of neurological conditions her special interests include rehabilitation medicine, movement disorders and neurotoxin therapy for neurological disorders. She obtained both a Bachelor of Medicine and Surgery as well as a Master of Medicine in Neurology degree at the University of Pretoria. She also holds a fellowship from the College of Neurologists, South Africa. She serves on various advisory committees and is a consulting neurologist at Life Groenkloof Hospital.

Jiwon Oh (Canada)

Dr Jiwon Oh is a staff neurologist, scientist, and Medical Director of the Barlo Multiple Sclerosis (MS) Programat St. Michael’s Hospital, University of Toronto and specializes in the care of people living with MS. Dr. Oh’s research focuses on developing advanced MRI techniques in the spinal cord and brain for use in clinical settings. She leads the MRI research program at St. Michael’s Hospital, and is the principal investigator on numerous local and multi-center collaborative studies, including the Canadian Prospective Cohort Study to Understand Progression in MS (CanProCo), which is a national prospective cohort study designed to better understand progression in MS. Dr. Oh is also the Secretary and an Executive Committee member of the North American Imaging in MS Cooperative (NAIMS) representing a multi-national collaborative MRI research endeavor in MS with over 35 sites in North America. She is deeply committed to caring for people with MS, educating future generations of clinicians and scientists, and contributing to scientific developments that will drive the field forward.

Friday 20 May 2022

Britta McLaren (SA)

Dr McLaren is a Paediatric Neurologist practicing at Morningside Mediclinic. Dr McLaren is a general paediatric neurologist with special interests in spinal muscular atrophy, epilepsy and equity in health care. In both the private and state health care settings in South Africa, access to health care remains a challenge that needs to be tackled. Addressing this challenge is a passion of DrMcLaren.

George Gericke (SA)

Prof Gericke is a registered paediatrician and clinical geneticist with extensive experience in both academics and industry and is particularly interested to bring these worlds together. He did a doctorate in Human Genetics at UCT. He previously did research at the Brain Function Research Unit at Witwatersrand University and was a member of the Tourette Syndrome Association International Genetics Consortium for about 10 years from 2000 onwards, working with Prof David Pauls from Harvard (Neuropsychiatric Genetics) and Professor Frank Wood from Wake Forest University (on the genetics of Afrikaner dyslexia.) He was HOD of Ampath Genetic Laboratories in Centurion from 1999 to 2022 and is currently Extraordinary Professor in Human Genetics at the Faculty of Health Sciences at the University of Pretoria. Current research interests include genetic plasticity:instability thresholds, fetal brain temperature in response to hypoxic stress and the downstream management of information about gene variants of unknown significance following gene sequencing studies.

Izelle Smuts (SA)

Professor Izelle Smuts is a registered paediatric neurologist employed in the Department of Paediatrics and Child Health, Steve Biko Academic Hospital, and University of Pretoria. She is head of the Paediatric Neurology Unit managing the entire spectrum of paediatric neurology and neurodevelopmental disorders including autism, cerebral palsy, epilepsy, neuromuscular disorder and other neurogenetic disorders. The Unit is also involved in pre-and post-graduate training of medical students in Peadiatrics, as well a paediatric neurologist. The Unit has recently joined International Centre for Genomic Medicine in Neuromuscular and Neurogenetic Diseases (ICGNMD research programme). Considering that her PhD was about the clinical and biochemical approach to mitochondrial disorders in the South African context, this brings the genetic link to not only mitochondrial conditions, but also related conditions treated in the clinic. It is a unique opportunity to unravel these very difficult to diagnose conditions in our population.

Shahida Moosa (SA)

Professor Shahida Moosa isan internationally-trained clinician-scientist. After completing her specialty training at Wits University, she obtained her PhD at the University of Cologne, Germany (summa cum laude), followed by a postdoctoral fellowship at Harvard Medical School and Boston Children's Hospital. She is currently a senior medical geneticist at Tygerberg Hospital and leads the Rare Disease Genomics in South Africa research group at Stellenbosch University. Prof Moosa is very passionate about bringing genomics to Africa and using these technologies to benefit African patients. With their “Undiagnosed Disease Programme”, Prof Moosa’s research team has provided definitive genomic diagnoses to 51% of the previously undiagnosed, thereby ending their diagnostic odysseys and proving the clinical utility of genomic testing in South Africa. Her interest in Neurogenetics was sparked by the transformational results seen when she introduced genetic testing into the paediatric epilepsy clinic at Tygerberg Hospital. She believes that early testing in epilepsy is key, but that for adult patients, especially, it is never too late for a diagnosis.

Johan Smuts (SA)

Dr Smuts is a neurologist currently working in a private practice in Pretoria. He completed his undergraduate training as well as his specialization at the University of Pretoria (1984 and 1993). He also did post graduate studies in Boston in the USA. In 2012 he completed a law degree at the University of South Africa.Dr. Smuts is a member of the South African Neurology Society and served on the executive council. He also is a past president of Pain SA. He has written several papers and chapters in books. Also, he participated in more than 70 clinical trials as principal investigator or sub investigator; the studies included studies on Alzheimer’s, Parkinson’s disease, MS, Headache, Stroke and Epilepsy. He presented papers at more than 25 local and international congresses. In the recent past he developed an interest in neurogenetics. While busing him with this he became increasingly interested in the impact that diet and other lifestyle changes has on many neurological conditions.

Martin Duddy (UK)

Dr Martin Duddy studied biochemistry and medicine at Queen’s University Belfast, graduating in 1992. His clinical training and post-graduate research in neurology were at the Royal Victoria Hospital, Belfast and the Montreal Neurological Institute, Canada. He was appointed a consultant neurologist with a special interest in MS at the Royal Victoria Infirmary, Newcastle upon Tyne in 2003 and is Clinical Director for Neurosciences. He was clinical lead for the UK MS Risk Sharing Scheme and is local principal investigator and UK chief investigator for a large number of collaborative studies. He is involved in clinical research, acting as local primary investigator for a large number of collaborative studies and is the editor of the Topical Reviews section of the Multiple Sclerosis Journal.

Sachin Kedar (USA)

Professor of Ophthalmology and Neurology
Vice Chair for Education
Emory University School of Medicine
Dr. Kedar is professor ophthalmology and neurology at the Emory University School of Medicine and Vice Chair for Education in the department of Ophthalmology. He graduated from India’s premier medical school, the All India Institute of Medical Sciences (AIIMS), New Delhi followed by residency training in ophthalmology and neurology, and fellowship training in neuro-ophthalmology and clinical neurophysiology. He is a fellow of the North American Neuro-ophthalmology Society (NANOS), the American Academy of Neurology (AAN) and American Neurological Association (ANA). He has significant expertise in medical education and administration, having served as the neurology residency program director for 10 years and ophthalmology core faculty for 5 years. He is the current chair of the NANOS curriculum committee. He has received numerous teaching awards including the NANOS Merit Award, AAO achievement award and the AAN excellence in teaching certificate. He has more than 80 journal publications, book chapters and online educational materials. He developed the standard curriculum in neuro-ophthalmology, and serves as the editor in chief of NANOS Illustrated Curriculum. With industry collaboration, he built the virtual reality based Advanced Pupil Simulator featured on NPR recently (http://netnebraska.org/interactive-multimedia/television/what-if-unmc-iexcel). His research interests include development of novel teaching methods, ophthalmic biomarkers of neurological diseases, clinical trials in neuro-ophthalmology and the impact of visual impairment on cognition. His clinical practice includes the entire gamut of visual disorders resulting from neurological diseases.

Anand Moodley (SA)

Prof Anand Moodley is consultant neurologist at Inkosi Albert Luthuli Hospital and at the University of KwaZulu-Natal since March 2021. He has previously served as HOD of neurology at the University of the Free State. He completed a neuro-ophthalmology fellowship in Vancouver, Canada and has a special interest in eye movement disorders. His focus of research lies in neuro-ophthalmology, and he takes much pleasure in the teaching of general neurology and neuro-ophthalmology to undergraduate and post graduate students. He supervises masters and doctoral students and plays an active role in the college of neurology as examiner.

Tony Marson (UK)

Professor Marson is a consultant neurologist and epileptologist at The Walton Centre, Professor of Neurology at The University of Liverpool and Director of Research Programmes at Liverpool Health Partners. The team at The Walton Centre runs one of the largest epilepsy services in the UK, providing a comprehensive multidisciplinary. His research has focussed upon the assessment of treatments. Interventions and services for epilepsy, and has informed policy, service and treatment decisions worldwide. He leads the National Audit of Seizure Management in Hospitals and chairs the current NHS England review of epilepsy specialist commissioning. He has coordinated the largest randomized controlled trials in epilepsy, and is chief investigator of the recently completed NIHR HTA trial of Standard and New Antiepileptic drugs II (SANAD II), and is the Coordinating Editor of the Cochrane Epilepsy Group. He is also a Board Member of the European Academy of Neurology where he chairs the Congress Programme Committee.

Elizabeth de Stadler (SA)

Elizabeth de Stadler is the founding director of Novation Consulting (Pty) Ltd. She is a rehabilitated attorney specialising in compliance and risk management strategy, plain language drafting and data protection law. Elizabeth loves Lego, t-shirts, sneakers, zombies and white wine. She hates comic sans font, sweet potato and most other attorneys. She is very scared of moths

Ralf Gold (Germany)

Professor Ralf Gold was heading the Institute for Multiple Sclerosis Research, University of Goettingen and Gemeinnützige Hertie-Stiftung, until he took the chair of the Department of Neurology, University of Bochum at St. Josef-Hospital in August 2006. Here the annual number of MS patients comes to more than 1200 outpatients and 800 inpatients. Dr. Gold’s main scientific interest is in translational therapies for multiple sclerosis, experimental immunotherapies in the animal models for multiple sclerosis and Guillain-Barré syndrome, and neurobiological disease modulators. He served as leading clinical physician and as principal investigator in a number of controlled therapeutic trials in multiple sclerosis, and is involved in several scientific research programmes and advisory boards. Until December 2018 he was past-president of German Neurological Society and leader of the German MS network panel KKNMS. Together with Prof. Montalban he coordinated the European MS guidelines. At the Bochum faculty Prof. Gold currently holds the Dean position on a honorary basis.Dr. Gold is also a member of a number of societies including American Academy for Neurology, Fellow of the European Academy for Neurology and board member of the German Kompetenznetwork Multiple Sclerosis. He has received several scientific awards for his experimental and clinical studies. Also he contributes to several editorial boards. From his scientific work more than 450 original publications and 160 review articles were published, with a h-Index of 80.

Saturday 21 May 2022

Alison Bentley (SA)

Dr Alison Bentley has been involved with sleep medicine and research for 30 years. She completed an MBBCH at Wits followed by a PhD on Restless legs Syndrome also at Wits in 2007. She developed the Dial-a-Bed Sleep laboratory) in the school of Physiology at Wits into one of the leading sleep research entities in South Africa. She is still active in research having supervised over 30 Master students and 5 PhD students in multiple topics and co-authored 35 journal articles. She left Wits to open a private practice dedicated to sleep disorders and managed a sleep laboratory including all sleep study scoring and reporting of sleep studies at Morningside Hospital from inception in 1991 to 2002. She was the founding chairperson of the South African Sleep Society in the late 1990s and is the current chairperson of the South African Society for Sleep and Health (SASSH). She has also represented Africa on the governing body of the World Association of Sleep Medicine. Dr Bentley is nationally recognised as an expert on various sleep disorders, including adult and child insomnia and obstructive sleep apnea. Currently she has a private practice devoted to sleep disorders as well as a company which performs home-based apnea screening studies as well as CPAP titrations.

Eitzaz Sadiq (SA)

Dr Eitzaz Sadiq (South Africa) is a Consultant Neurologist and Lecturer at the University of the Witwatersrand, Johannesburg and the Head of the Neurology Unit at Helen Joseph Academic Hospital. He has a keen interest in stroke, particularly regarding risk prediction and prevention of stroke. He is currently enrolled in a PhD at the University of the Witwatersrand exploring Risk Predictors for Stroke in the Setting of HIV Infection, and has been involved in numerous publications and presentations on the subject. He has a passion for learning and teaching the art of clinical neurology, and dedicates a large amount of time to Undergraduate and Postgraduate training and mentorship. He is a vocal advocate for patients’ rights to an exceptional and efficient service, but above all, their rights to dignity, care and comfort. He is a humorous and witty husband to his wife Louisa, and an energetic and loving father to their 5 young children, and enjoys playing cricket and the piano when not road-tripping with his family.

Andreas Engelbrecht (SA)

Prof. Andreas Engelbrecht has been a member of the council of the College of Emergency Medicine since 2010. He is an examiner, moderator and convener for the fellowship exam in emergency medicine of the college of emergency medicine of South-Africa as well as the diploma in primary emergency care. He is a member of the national snake bite advisory group (NSAG) which advises doctors on the management of snakebite and has been co-opted onto the WHO (world health organization) panel of experts on snakebite. Prof. Engelbrecht is an ATLS (advanced trauma life support) instructor and course director. Prof. Engelbrecht is also an instructor on the EGLS (echo guide life support) course and is an EMSSA (emergency medicine society of south africa) basic ultrasound instructor. Prof Engelbrecht is the course director for the MMed (emergency medicine) at the University of Pretoria. He developed three popular emergency related short courses for the University of Pretoria namely the EMpret ECG course, The EMpret VAPP (venomous animals and poisonous plants) course and the EMpret airway course.

Jacques Badenhorst (SA)

Dr Jacques Badenhorst is currently completing his 5th year of registrar training in diagnostic radiology at the University of Pretoria. His interest in the field includes neuroradiology and cardiac imaging.He obtained his medical degree in 2012 from the University of Pretoria after which he completedhis internship and community service in academic centres in Gauteng. Outside of medicine, he enjoys spending time with the family, nature and the occasional round of golf.

Louis Kroon (SA)

Dr Kroon is an attending neurologist at Steve Biko Academic Hospital and lecturer at the University of Pretoria. He completed his neurology registrars training at the University of Pretoria (with Distinction) and is currently working on his doctoral dissertation. His most recent published work includes an article in the journal of Stroke and Cerebrovascular disease on the risk factors of HIV and Stroke for which he also received the reward for best NASA/AFAN research presentation in 2019. Dr Kroon also facilitated the Diamond Stroke Status award for Steve Biko Academic Hospital in 2022. Currently he serves as an examiner for the colleges of medicine of South Africa, and is part of the Committee of the Civil Aeromedical Association. He is also setting up the AAN’s Residency in Training Examination program (RITE) at the University of Pretoria.

Elsabe Klinck (SA)

Elsabė Klinck is the Managing Director of Elsabe Klinck & Associates, specialises in health law, -policy and -ethics.She holds degrees in law, German and applied psychology.
Elsabė has worked in the health sector since 2001:
• first at the SA Medical Association as legal advisor;
• at the Foundation for Professional Development as Director of Compliance and Consulting;
• in the pharmaceutical sector at a trade association;
• and at a prominent healthcare consultancy.
Prior to her health sector involvement, Elsabė was a senior lecturer in the Department of Constitutional Law at the Free State University, where she worked for 8 years. She now owns a successful healthcare consulting firm (Elsabe Klinck & Associates), serving clients in the pharmaceutical, medical device, healthcare professional and health facility markets all over South Africa. Elsabė has published- and spoken widely on topics relating to constitutional law, human rights, health law, ethics and social security. She is co-author of, amongst others, the books Employment Equity Law and International Human Rights Standards and has published chapters in Social Security Law. She has undertaken research for, amongst others, the Taylor Committee of Enquiry into Social Security and the SA Business Coalition on HIV & Aids.

Lawrence Tucker (SA)

Lawrence Tucker is head of the Division of Neurology at Groote Schuur Hospital and the University of Cape Town. He did his clinical training in Cape Town but also holds a Masters degree from the UNiversity of London and a PhD from Cambridge.He is President of the College of Neurologists of South Africa and past president of the Neurological association of South Africa. He is also a vice president of the African Academy of Neurology .He has broad professional and academic interests in neurology, but epilepsy and postgraduate neurology education are his passions. In 2017, together with emeritus professor Roland Eastman and Dr Eddy Lee Pan he conceived of and developed the Web-based EEGonline distance learning program for electroencehalography. Over the 5 years since then, in excess of 1000 neurology registrars, neurologists and neurotechnologists have enrolled for this 6-month course from all over the world.

Ray Chaudhuri (UK)

Professor K. Ray Chaudhuri is Professor of Neurology/Movement Disorders at King’s College Hospital and King’s College London and the Medical Director of the Parkinson Foundation International Centre of Excellence at King’s College. He is internationally known for pioneering modern care for people with Parkinson’s particularly advanced therapies in addition to care for restless legs syndrome. He is the founding Chairman of the International Movement Disorders Society Non-motor Study Group and member MDS-ES Education and palliative care committee and ex Chair of the MDS Membership and Public Relations committee as well as member MDS congress scientific programme committee (2013–2017). He is the founding and consulting editor and ex editor-in- chief of the Nature group Nature Parkinson’s journal (2020 Impact Factor 8.8) as well as guest Editor for special editions of Frontiers in Neurology, Journal of Personalised Medicine (Impact Factor 4.8), Movement Disorders in Older Adults (Geriatrics) and Journal of Parkinson’s Disease, reviewer for all mainstream Movement Disorders journals as well as JAMA, Neurology, Annals of Neurology, BMJ, Brain, Lancet and JNNP. He serves as an advisor (MHRA health technology and scientific advisor) to NICE as well as GMC, Parkinson’s UK and EPDA. Professor Chaudhuri is the author of over 480 papers ( 6th most published author in the world in PD 2022,Expertscape) , co-editor of five books on Parkinson’s disease and restless legs syndrome and winner of the BMA book prize commendation in 2015 and 2017. He won the Andrew Wilson Prize for services to RLS patients by RLS: UK, William Koller Memorial Fund Award by MDS, the 2018 Van Andel award in the USA for outstanding nonmotor research contribution in the field of nonmotor Parkinson, as well as NIHR/Royal College of Physicians London award for outstanding research leadership in 2017. He has been a guest lecturer worldwide including Japan, China, Taiwan, Vietnam, Thailand, Singapore, Australia, India, Africa, USA, Russia and Europe. In 2020 he was elected as lead for Equality Diversity charter for NIHR London South Applied Research Collaboration (ARC) and was elected as a Honorary Member for the Movement Disorders Society in 2021. In 2022 he was awarded UK NHS Gold merit award.

Regina Katzenschlager (Austria)

Professor Regina Katzenschlager, MD, is Consultant Neurologist, Guest Professor at Vienna Medical University and the Head of the Department of Neurology and Geriatrics and of Karl Landsteiner Institute for Neuroimmunological and Neurodegenerative Disorders at KlinikDonaustadt, Vienna, Austria, a teaching hospital affiliated with Vienna Medical University. She trained in neurology, psychiatry and geriatric medicine in Vienna and did a 3-year fellowship in movement disorders at Queen Square, University College London, UK. Her research focuses on treatments for Parkinson´s disease and evidence based medicine. She is the Vice President of the Austrian PD Society, a past president of the Austrian Neurological Society and has served in numerous roles for the International Parkinson and Movement Disorders Society (MDS), including as Chair of the Evidence-Based Medicine Committee and currently as member of the International Executive Committee.

Lucia Batzu (UK)

Dr. Lucia Batzu is a Clinical Research Fellow to Professor Chaudhuri at King’s College London and the Parkinson’s Foundation Centre of Excellence, King’s College Hospital, London. She is interested in both motor and non-motor aspects of movement disorders, with a focus on cognitive dysfunction in Parkinson’s and molecular pathology and neuronal networks in genetic Parkinson’s disease.She has been a Research Associate in the Division of Clinical Geriatrics at the Department of Neurobiology, Care Sciences and Society at Karolinska Institute (Sweden), working on several research projects on neuroimaging in neurodegenerative diseases.She graduated in Medicine at the University of Sassari (Italy) and recently completed her training as a Neurologist with the highest marks.Lucia is currently working as a Clinical Trials Physician at King’s College Hospital London. She is also a member of the International Parkinson and Movement Disorder Society (IPMDS).

Susan de Bruin (SA)

Dr de Bruin is a GP with a passion for delivering home based palliative care for the patients of Pretoria. She completed her Postgraduate Diploma in Palliative Medicine at the University of Cape Town in 2009 and is currently working on MPhil Pall Med. She started her career in Pall Med in 2008 at Sungardens Hospice in Pretoria where she focused on home visits. Recognising the need for palliative medicine and home visits in the community outside oncology, especially geriatrics and neurodegenerative diseases inspired her to begin her mobile practice in 2019. Susan is a member of PalPrac (The Association of Palliative Care Practitioners of South Africa) and on the board since it was founded in 2018.